PHAR vs IVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

PHAR

22.7
AI Score
VS
IVA Wins

IVA

25.7
AI Score

Investment Advisor Scores

PHAR

23score
Recommendation
STRONG SELL

IVA

26score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric PHAR IVA Winner
Forward P/E 243.9024 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 20.8% -76.7% PHAR
Earnings Growth 74.9% 0.0% PHAR
Tradestie Score 22.7/100 25.7/100 IVA
Profit Margin 6.2% 0.0% PHAR
Beta 1.00 1.00 Tie
AI Recommendation STRONG SELL AVOID NEW MONEY IVA

Relative Price Performance (Last 90 Days)

PHAR 1M: +41.9% · 3M: +8.5% IVA 1M: +39.7% · 3M: -12.8%

Current Technical Phase

PHAR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 73

RSI (14): 73.1 · Price: $13.40

IVA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 60.2 · Price: $4.01

Fundamentals Snapshot

Metric PHAR IVA
Market Cap — —
Forward P/E 74.4 -5.6
Trailing P/E 41.3 —
Revenue (TTM) — —
Revenue Growth 0.2% -0.8%
Gross Margin 0.9% 0.8%
Operating Margin 0.3% -53.4%
EPS 0.32 -0.62
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IVA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.